The overexpression of RCOR2 in endometrial cancer tissues and its correlation with advanced clinical stages, higher histological grades, and lymph node metastasis suggest that RCOR2 may drive tumor progression through various molecular pathways. Here, RCOR2 is linked to neoplasm.